Henlius' Serplulimab Granted Orphan-Drug Designation in the United States for Small Cell Lung Cancer
/PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the United States Food and Drug Administration (FDA) has granted Orphan-Drug...